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THE use of enzymes as chemotherapeutic agents for the control of tumour
growth has found comparatively little favourwith experimenters ofthe past. The
reasons for this are indeed understandable, as pointed out by Bergel (1961) in his
account of the control of enzyme activities in tissues. Difficulties which arise
concern the availability ofthe enzyme preparations, the immunological incompati-
bility of " foreign " proteins and the problem ofpermeability ofthe cell membrane
to the comparatively large enzyme molecules. The first difficulty could be over-
come through the use of modern preparative methods and the second through
counteracting agglutinations by treatment with adreno-cortical preparations.
The problem of transport of the enzyme into the cell will be discussed below.
Therapeutic experiments with enzymes, similar to the ones carried out in this
work, have been reported before, when Haddow, de Lamirande, Bergel, Bray and
Gilbert (1958) injected xanthine oxidase into tumour-bearing mice in an attempt
to retard tumour growth. The choice ofthe enzyme in the present studies for the
purpose ofimpeding or atleast, retarding tumourgrowthwasguided bythe follow-
ing previous observations: arginine had been shown to exert a stimulating effect
on the mitosis of mouse carcinoma (Bach and Lasnitzki, 1947) and to be exces-
sively utilised in the synthesis of creatine in rats bearing Jensen sarcoma (Bach
and Maw, 1953). Therefore, an enrichment ofthe tissues witharginase could have
been expected to reduce the level of arginine in these tissues and to diminish its
value as a stimulating agent, particularly so, since the work ofBach and Lasnitzki
(1947) had also indicated that slow-growing tumours contained less arginase than
fast-growing tumours. Subsequently, it was indeed observed that arginase added
to tissue cultures of fibroblasts and to cells of Jensen sarcoma completely inhi-
bited mitosis in the metaphase at very low enzyme concentrations (Bach and
Simon-Reuss, 1953). Thus an in vivo approach to the problem, i.e. injections of
arginase into tumour-bearing animals was the logical choice of experiment.
The authors received little encouragement for this project since Greenberg and
Sassenrath (1953) failed to reproduce the favourable results obtained in vivo
experiments by Vrat (1951), Wiswell (1951) and Irons and Boyd (1952). These
authors had claimed to have succeeded in controlling tumour growth in mice by
injecting crude arginase solutions. However, in the meantime arginase prepara-
tions ofhigher purity have been made available (Bach and Killip, 1958 and 1961;
Bach, Hawkins and Swaine, 1963). Such highly purified preparations when used
in the present work for injections into rats bearing Walker carcinomas, resulted in
a considerable retardation of tumour growth.
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MATERIAL AND METHODS
Arginase preparations.-The enzyme used in these experiments was prepared
from ox liver according to a method similar to or identical with that of Bach,
Hawkins and Swaine (1963); the preparations were taken to the " pre-crystallisa-
tion stage" of this method. The unit of arginase activity was defined as that
amount of enzyme which liberates 1 #1 urea-CO2 (1/224 It mole) from a 0 05 M
L-arginine hydrochloride solution in 10 minutes at 300 and at pH 9 0. The
specific activity of the enzyme solution was defined as activity units/mg. protein-
nitrogen; the protein-nitrogen was determined spectrophotometrically (Bach and
Killip, 1958).
Animals.-200-250 g. rats were used. They were albinos of the Chester
Beatty strain and were fed throughout on standard laboratory diet.
Implantation and measurement of tumours.-The Walker 256 carcinoma was
used throughout. Solid fragments of tumour were removed under sterile con-
ditions from tumour-bearing rats andimplanted into otherratsbymeans oftrochar
and cannula under general anaesthetic. After 5-8 days the new tumour had
reached a palpable size and was large enough for the experiments to commence.
In each experiment 8-10 animals were assigned to both the control and experi-
mental groups. The tumours were measured in cm. in two dimensions with
calipers and the area (cm.2) so obtained, constituted the tumour area.
Injections.-AII injections (of usually 0-5 ml.) were made intra-peritoneally at
daily, or at 2 day intervals.
Enzyme dose.-This varied considerably in the different experiments, ranging
from 1,000 to 137,000 enzyme units in extreme cases.
Statistical analysis.-The significance of the difference between the changes in
tumour size of the control and experimental animals was calculated for each
experiment using the Student " t " test, and was expressed as probability " p ".
The relative significance ofthe occurrence ofan accelerating or retarding effect
on tumour growth was assessed by a chi-squared test. Chi-square = 2(- In p).
Tables of chi-square were entered for the appropriate degrees of freedom, in this
case, twice the number of experiments under consideration.
RESULTS
The object of this study was to investigate the effect of injections of arginase
solutions into tumour-bearing rats on the growth of their tumours.
Compilation of the results in Table I.-The results listed in Table I involved 18
experiments with a total of 360 rats, about halfthe number ofwhich were injected
intraperitoneally with highly purified arginase solutions, while the other half
were injected with saline. The tumour areas of the controls and of the enzyme-
injected rats were measured at intervals of 1, 2, 3 or 4 days after the first
injection. In some of the 18 experiments the tumours were measured on each
ofthe 4 days, in others only on some ofthese days. From the differences between
the tumour areas of those measured on the day of the first injection and those
measured on the 1st, 2nd, 3rd or 4th day after the injection, the changes in tumour
areas were obtained both for the controls and the enzyme injected rats. These
changes were averaged for eachexperiment (involving about 20rats) andthemean
changes so obtained are listedin Table I for each of the 4 days of observation. In
this way, each of the pairs of values in Table I represents the mean area changes
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TABLE I.-The Effect ofArqina8e on Tumour Growth
Mean changes in tumour area (cm.2) ± S.E.M.
1st Day
after initial injection of:
Saline
0 73+0 5
2-25±0-3
3-66+0-6
3-38±154
1 43±0* 3
1-314±0*3
3-96+0-5
2-30±0-2
1 46±0 5
1-01±0-2
1-43±0 3
2 17±0- 3
(95 rats)
Ar
-054
1* 8
2.0f
1 32
1.39
1. 63
4 0$
2*29
0 04
1 *11<
0.91
ginase p
t+0 5 0-1
3+0 7 >0-1
B*0-4 >0- 1
2+0-4 >0- 1
3+0 5 >0.1
3L0L1 >0*1
5+0 5 >0.1
)±0 5 >0- 1
t+0 7 >0-1
2±04 >0-1
140*1 0-1
1 55+0*4
(90 rats)
2nd Day
after initial injection of:
I I r
Saline
L 1-70±0-3
L 4*66±0-3
6 110-7
4-43±0 5
L 2-210-3
3 39+0 5
L 6-83+0*8
L 5 58±0-6
4-57+0-4
L 1-01+0-2
1-38+0-5
- 3-30±0-81
- 7 39±0 4
- 4-22±1-2
Arginase
0.40+0.3
3 94+0 9
6*18+0-1
2*38+0*2
3-43+13
3-38+0 7
7- 18+0- 6
4*61±0-6
3-81±0-8
2-76+0-5
0-86±0*2
0*12+0*4
5 48+0- 7
1 38+0 5
p
0-01
>0-1
>0-1
0-01
>0*1
>0*1
>0-1
>0 1
>0-1
0*0002
>0*1
0-0002
0-02
0-06
4 33+0 5 3-39+0-6
(133 rats) (127 rats)
3rd Day
after initial injection of:
o- A
Saline
3-77+1-2
6-910-8
7 - 65± 1- 0
7-14+0 9
3 430Q 3
5 78±0 7
8-5851+6
7-85±0-9
7-23±0-5
4* 45±0 1
5-610-6
4 700* 3
6- 11+0- 5
(119 rats)
Arginase
1 40+0 5
4 72±0 9
7-26+1*0
4 40±0 7
4-54±1 3
5 43±0 3
9 28±1 1
7-50±1* 2
6-58±0-7
2- 17+0- 6
1-53±+0-6
5-59+0-8
4-84±0-7
(117 rats)
4th Day
after initial injection of:
p
0 06
0o09
>0*1
0*03
>0-1
>0*1
>0*1
>0-1
>0-1
0 003
0 0004
>0-1
Saline
3 44±0 7
10-64±1 3
8-71±1* 2
8-83±1 2
5- 13±0-4
7-75±0-8
2-58±0-9
6*88+0*7
11* 85±0. 5
7-44+1 4
Arginase
1*40+0*5
5*52+1*3
10-30+1*4
5*90+1* 1
6 33+1*8
7 35+0 3
2*12+0X5
4X30±00 9
9 93±0*9
4 52±0i 8
p
0-02
0-01
>0-1
0.1
>0-1
>0-1
>0-1
0*07
>0*1
0.1
. 7*88+0*9 6*34±0*9
(92 rats), (103 rats)
The pairs ofvalues constitute the mean changes in tumour area after 1-4 days oftumour growth as
observed with the approximate 20 rats involved in each experiment, half ofwhich had received daily
injections with arginase solution. The probability p was calculated according to the Student t-test.
of the tumours in one particular experiment and at one particular period of
tumour growth. Since, as mentioned above, the same group of rats could not
always be used for all 4 days of observation, only 10-14 pairs of area changes
(instead of 18), together with their S.E.M. values, will be found in each of the 4
sections of the table. The significance of the differences in the growth rates of
the tumours between the two categories of treatment is expressed by the p value
for each experiment and for each day of observation.
A typical experiment (Exp. No. 9) is presented in Table II which shows the
Number
of
experiment
28
8a
8b
4
18
16
24
23
25
17
19
12
9
6
18a
Number
of
experiment
28
8a
8b
4
18
16
24
23
25
19
12
9
6
15
11
7
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mean tumour areas in the initial stage aswell as 2 and 4days after the first arginase
injection.
TABLE II.-Mean Tumour Areas of Saline Treated and Arginase treated Rats
(Summary ofa typical experiment, No. 9)
Saline treated Arginase treated p
Number ofanimals . 17 . 18
Initial area (cm.2). . 4- 56±0 26 . 4*96±0 23
2 days treatment . . 11-99±047 . 10-53±0 86
4 days treatment . . 16.48±0.57 14-910 84
Differences
0-2days . . 7-42+045 5-57±0-71 . 0 04
0-4days . . . 11-90±0-52 . 995+0-84 . 0-06
Interpretation ofTable 1.-An examination ofthe results in Table I shows that
the average increase in tumour area in all experiments carried out on each of the
four days of observation, (i.e. the average growth rate of the tumours during a
particular period), was markedly lower with the arginase-treated animals than
with their controls. On the other hand, an examination of the individual experi-
ments recorded in the four sections of Table I reveals that of the total of 47 mean
changes listed, the injection of arginase apparently caused growth retardation
only in 32 cases, while a growth acceleration was found in 10 experiments; in
the remaining 5 experiments, where the difference in the mean change of tumour
area between saline and enzyme-treated animals was lower than 0 9 cm.2, the
enzyme was considered to have no effect.
Statistical significance of the results in Table I.-Out of the 32 " effective"
experiments, statistical significance can only be claimed for 11 for which, except
for two values of 0-06, the probabilities were all 0 03 or even considerably lower.
Table III.-By applying the chi-squared test for the determination of the
comparative significance ofthe retarding and the accelerating effects ofarginase on
tumour growth, it was found that for the 2nd, 3rd and 4th day ofobservation, the
retardation of tumour growth by arginase was highly significant (Table III). In
contrast to this, the results which showed an apparent accelerating effect of the
enzyme were not statistically significant.
TABLE III.-The Comparative Significance ofthe Accelerating and Retarding Effects
ofArginase on Tumour Growth
(Chi-squared Test)
Period after Experiments Number of
first injection showing: experiments Number ofrats Probabilities
p
Day 1 . Growth retardation . 8 . 110 . 090
Growth acceleration . 3 . 75 . 0.97
Day 2 . Growth retardation . 10 . 193 0-002
Growth acceleration . 4 . 67 . 0- 15
Day 3 . Growth retardation 9 . 172 . 00001
Growth acceleration . 3 . 64 . 0-54
Day 4 . Growth retardation . 8 . 168 . 0-01
Growth acceleration . 2 . 27 . 0 43
Chi-squared was calculated from Y2(-ln p). P was found by entering tables of chi-squared for
the appropriate degrees of freedom (twice the number of experiments). The values for p in experi-
ments showing retardation or acceleration of tumour growth were taken from Table I.
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Enzyme concentration and growth-retarding effect (Fig. 1).-Depending on the
particular enzyme preparation, the enzyme concentrations in the solutions used
for the injections varied substantially in the individual experiments. With this
in mind, the results listed in Table I were examined for a possible influence of the
enzyme concentration on the growth-retarding effect. For the purpose, the
enzyme effects observed after 1, 2, 3 and 4 days were grouped together and the
mean enzyme effect per day on tumour growth, i.e. the average daily arginase
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FIG. 1.-The effect of the concentration of injected arginase solutions on the retardation of tumour
growth.
effect, was calculated for each experiment; experiments in which measurements
had been taken on one single day only, were not included. When the enzyme
effects of 14 out of the total of 18 experiments were plotted against the enzyme
concentrations used in these experiments, a striking correlation was found between
the two variables, in that the lower enzyme concentrations were more effective
than the higher ones. The correlation coefficient was calculated and the best
fitting line was drawn (Fig. 1) (Moroney, 1956).
Specific activity of the enzyme and growth-retarding effect.-When the specific
activities (" purity ") ofthe enzyme solutions used for the injections were plotted
against the growth-retarding effects, no correlation was found. On the contrary,
the values were distributed at random.
DISCUSSION
The results presented here, together with their statistical evaluation, indicated
that daily intra-peritoneal injections of suitable concentrations of arginase were
accompanied in the majority of cases by a noticeable retardation of tumour
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growth. The retardation was maintained at least for 4 days, though it could only
be observed in 32 out ofa total of47 experiments, each involving about 20tumour-
bearing rats. One of the reasons for the failure of arginase to exert a retarding
effect on tumour growth in the remaining 15 experiments may possibly be the high
enzyme concentrations used in many of these cases, as will be discussed below.
Thus the average retarding effect for all experiments was 20%-30%, depending
on the period of tumour growth within the 4 day observation period. However,
the retardation of tumour growth in the 32 " effective " experiments was 31 %-
77 %, with the greater effects observed in the earlier periods of tumour growth.
The retarding effect of the enzyme injections on the growth rate of the tumours
could be expected to lead eventually to tumour regressions. However, the
incidence ofregression was found to be only insignificantly higher in the arginase-
treated animals (26/177) than in the controls (20/183).
Though the statistical significance ofthe differences between the mean changes
in tumour size ofthe control and the experimental animals in the " effective cases "
was limited to only 11 experiments, the very high comparative significance of the
retarding effects of the enzyme (chi-squared test), on the 2nd, 3rd and 4th day of
tumour growth, as seen from Table III, can be considered encouraging. The
failure to obtain more significant results in the individual experiments of Table I
is understandable in view of the substantial biological variations; these find ex-
pression in the very considerable differences in the sizes of the initial tumours of
the 360 rats which varied in area from 0 4 cm.2 to 13-5 cm.2. The possibility of a
connection between the initial tumour sizes and the chance of obtaining an
arginase effect on the rate of tumour growth was explored. However, a statis-
tical investigation revealed no such correlation.
Effect of enzyme concentration.-In contrast to the appreciable retardation of
tumour growth observed after intraperitoneal injection of purified arginase
solutions in comparatively low concentrations, the lack ofefficacy ofhigh enzyme
concentrations has yet to be explained. It could be argued that this may be due
to difficulties concerning the absorption ofconcentrated solutions ofhighmolecular
matter from the peritoneum. However, it appears that the absorption of such
solutions andofparticulate matterintheunanaesthetisedanimal occurs principally
in the subphrenic region of the peritoneum where the passage for such matters is
relatively free (Yoffey and Courtice, 1956). It is true though that the work of
Allen and Raybuck (1960) indicates that the diaphragmatic lymphatic plexus may
not play the only part in the absorption ofperitoneal protein. Whether a further,
as yet unknown, mechanism of peritoneal absorption would be less efficient in
disposing of protein at higher concentrations than at lower ones, is a matter of
speculation.
Effect of impurities8.-The effectiveness of preparations with low enzyme
concentrations containing a large proportion of non-enzymic material, could be
interpreted as the result of an inhibiting action on tumour growth of certain
impurities in the preparations. However, the fact that no correlation was found
to exist between the specific activity (i.e. the purity) ofthe enzyme solutions used
and the enzyme effect, precludes this possibility.
Transport of the enzyme to and beyond the vascular system.-There is no doubt
that the intraperitoneally injected enzyme reaches the vascular system. Hawkins
(1963) found that after a single injection of 80,000 units of arginase into rats, a
considerable rise in plasma arginase levelswas obtained after a period of 1-2 hours.
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This activity disappeared after another 4-5 hours. In other experiments bovine
xanthine oxidase of a molecular weight of 300,000, injected intraperitoneally into
mice bearing spontaneous mammary carcinomas, was judged to have reached the
liver and tumour tissue, since the levels of this enzyme were raised in both tissues
proportionally to the quantity injected (Haddow, de Lamirande, Bergel, Bray
and Gilbert, 1958).
Whether the large arginase molecules (molecular weight 138,000, Greenberg,
1954) would actually reach the cell cytoplasm of any tissue, is another question.
Entrance into the cell membrane of large molecules is possible and pinocytosis is
one mechanism by which this could occur. Ghose, Nairn and Fothergill (1962)
injected rabbit serum proteins, labelled with a fluorescent dye, and detected the
proteins in the cytoplasm of malignant tissue and of Kupffer cells, but not in the
nuclei, although Watson (1959) had shown the existence of large pores in the
nuclear membrane. However, exogenous DNA was found by Bensch and King
(1961) to be incorporated not onlyinto the cytoplasm but alsointo the nuclei ofcells.
Even if administered enzyme were transported no further than to the inter-
cellular space, it could reduce the level of arginine within the cell by setting up an
" arginine gradient " through enforced destruction of that quantity of arginine
which is exchanged across the cell membrane. This could lead to a depletion of
arginine in the cytoplasm and, possibly, in the nucleus. In this way the synthesis
of the histones of nucleoproteins, rich in basic amino acids, would be impaired and
the rapid growth of malignant cells possibly checked.
SUMMARY
1. Intraperitoneal injections of highly purified arginase preparations into rats
bearing Walker carcinomas over a period of 4 days caused a 31 %-77 % retardation
of tumour growth in the great majority of cases, with the higher effects occurring
in the earlier periods. In a small number of cases no such effect or even a growth
acceleration was observed.
2. Owing to the considerable biological variations within the initial sizes of the
tumours of the 360 rats used, the retarding effects were statistically significant
only in a minority of cases. However, when the comparative significance of the
retarding and accelerating effects of the enzyme on tumour growths were investi-
gated, a high statistical significance was found fortheretardationandnosignificance
for the acceleration.
3. Lower enzyme concentrations apparently exerted a greater retarding effect
than higher ones. A possible connection between this correlation and the mode
of absorption of high molecular matter from the peritoneum is discussed.
4. Since no correlation was found between the purity ofthe enzyme preparation
and its retarding effect on tumour growth, the possibility of impurities being
responsible for the retarding effect could be excluded.
5. It is suggested that the presence ofarginase in the intercellular space may set
up an " arginine gradient " which could lead to a depletion of tumour tissue of
arginine with a resulting impairment of tissue growth.
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